close
Trend Chart on Innovative Biotherapies 29th August, 2019
News

Trend Chart on Innovative Biotherapies 29th August, 2019

FEATURE STORY
Pfizer adds 500MUS$ to gene therapy manufacturing plant
GENE THERAPY
AAV-ie enables safe and efficient gene transfer to inner ear cells.
Recent advances in the targeting of systemically administered non-viral gene delivery systems
DISRUPTIVE TECHNOLOGIES
Efficient electroporation of neuronal cells using synthetic oligonucleotides
Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
INDUSTRIAL LANDSCAPE & AGREEMENTS
Sarepta stumbles on FDA rejection of VyonDys53 to treat Duchenne muscular dystrophy
Zogenix announces acquisition of Modis Therapeutics
Mustang Bio announces license agreement with CSL Behring for the Production of MB-107 lentiviral gene therapy
MISCELLANEOUS
Circulatory miRNA biomarkers of metabolic syndrome

Click here to read these articles: Trend Chart on Innovative Biotherapies August 29th


COMMENTS ARE OFF THIS POST